The poison control centres referred to in article L. 6141-4 and the regional pharmacovigilance centres referred to in article R. 5121-167 shall transmit, without delay, to the Agence nationale de sécurité sanitaire, de l’alimentation, de l’environnement et du travail any information they have on adverse reactions in humans which may be attributed to the use of these medicinal products.